Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
DMRC Digimarc
- 12.890
- +0.415+3.33%
Close May 7 16:00 ET
- 12.890
- 0.0000.00%
Post 16:00 ET
277.81MMarket Cap-6.86P/E (TTM)
13.230High12.490Low242.90KVolume12.490Open12.475Pre Close3.12MTurnover1.75%Turnover RatioLossP/E (Static)21.55MShares48.32052wk High5.56P/B179.27MFloat Cap10.44052wk Low--Dividend TTM13.91MShs Float66.500Historical High--Div YieldTTM5.93%Amplitude7.611Historical Low12.825Avg Price1Lot Size
Digimarc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.74%9.37M | 10.24%38.42M | -6.74%8.66M | 4.99%9.44M | 18.89%10.38M | 26.71%9.94M | 15.41%34.85M | 28.62%9.28M | 15.00%8.99M | 12.69%8.73M |
| Operating revenue | -5.74%9.37M | 10.24%38.42M | -6.74%8.66M | 4.99%9.44M | 18.89%10.38M | 26.71%9.94M | 15.41%34.85M | 28.62%9.28M | 15.00%8.99M | 12.69%8.73M |
| Cost of revenue | -11.89%3.28M | -3.45%14.18M | -1.85%3.39M | -5.97%3.55M | -8.94%3.52M | 3.53%3.73M | -1.26%14.69M | 1.59%3.46M | 3.15%3.77M | 2.96%3.86M |
| Gross profit | -2.04%6.09M | 20.20%24.24M | -9.64%5.27M | 12.90%5.9M | 40.95%6.86M | 46.37%6.21M | 31.60%20.17M | 52.71%5.83M | 25.40%5.22M | 21.82%4.87M |
| Operating expense | 6.42%18.16M | -3.62%65M | -14.51%13.82M | 5.42%17.27M | 6.03%16.85M | -10.22%17.07M | -10.03%67.44M | 4.04%16.16M | -16.82%16.38M | -16.15%15.89M |
| Selling and administrative expenses | 2.02%10.26M | -5.53%38.24M | -24.68%7.76M | 7.13%10.5M | 4.99%9.93M | -7.95%10.06M | -16.82%40.48M | 3.66%10.3M | -17.07%9.8M | -24.70%9.46M |
| -Selling and marketing expense | -8.27%5.08M | -5.54%21.17M | -22.36%4.38M | 5.05%5.64M | 9.99%5.62M | -12.10%5.54M | -24.59%22.41M | -6.27%5.64M | -30.17%5.37M | -36.75%5.11M |
| -General and administrative expense | 14.62%5.18M | -5.52%17.07M | -27.50%3.38M | 9.65%4.86M | -0.87%4.31M | -2.31%4.52M | -4.61%18.07M | 18.91%4.66M | 7.28%4.43M | -3.01%4.35M |
| Research and development costs | 13.25%7.63M | -1.38%26.21M | 0.86%6.34M | 2.85%6.49M | 7.84%6.64M | -13.86%6.74M | 0.33%26.58M | -7.06%6.28M | -16.73%6.31M | 1.58%6.16M |
| Depreciation amortization depletion | -0.37%271K | 3.00%1.1M | 3.40%274K | 2.94%280K | 1.12%271K | 4.62%272K | 0.09%1.07M | 165.00%265K | -9.63%272K | -16.51%268K |
| -Depreciation and amortization | -0.37%271K | 3.00%1.1M | 3.40%274K | 2.94%280K | 1.12%271K | 4.62%272K | 0.09%1.07M | 165.00%265K | -9.63%272K | -16.51%268K |
| Other taxes | ---- | 19.59%-550K | ---- | ---- | ---- | ---- | 45.71%-684K | ---- | ---- | ---- |
| Operating profit | -11.26%-12.08M | 13.78%-40.76M | 17.26%-8.55M | -1.91%-11.37M | 9.40%-9.98M | 26.48%-10.86M | 20.73%-47.27M | 11.81%-10.33M | 28.15%-11.16M | 26.30%-11.02M |
| Net non-operating interest income expense | 8.21%1.82M | 125.81%1.68M | ||||||||
| Non-operating interest income | ---- | 8.21%1.82M | ---- | ---- | ---- | ---- | 125.81%1.68M | ---- | ---- | ---- |
| Other net income (expense) | -30.11%369K | 83.33%-27K | -6.34%-1.9M | 29.08%617K | 82.12%723K | -29.13%528K | 80.02%-162K | -22.81%-1.78M | -23.27%478K | 326.88%397K |
| Gain on sale of security | ---- | -128.13%-27K | ---- | ---- | ---- | ---- | 11.63%96K | ---- | ---- | ---- |
| Special income (charges) | ---- | --0 | --0 | --0 | --0 | ---- | 72.68%-250K | --0 | --0 | ---250K |
| -Less:Impairment of capital assets | ---- | --0 | --0 | --0 | --0 | ---- | -72.68%250K | --0 | --0 | --250K |
| Other non- operating income (expenses) | -30.11%369K | ---- | ---- | 29.08%617K | 11.75%723K | -29.13%528K | -144.44%-8K | -57.02%-1.88M | -23.27%478K | 595.70%647K |
| Income before tax | -13.37%-11.71M | 14.84%-38.97M | 17.33%-8.63M | -0.69%-10.75M | 12.82%-9.26M | 26.34%-10.33M | 23.36%-45.76M | 16.01%-10.43M | 28.35%-10.68M | 28.51%-10.62M |
| Income tax | 122.22%20K | -78.43%44K | -84.17%22K | -95.56%2K | 450.00%11K | -50.00%9K | 110.31%204K | 456.00%139K | 73.08%45K | 100.92%2K |
| Net income | -13.46%-11.73M | 15.12%-39.01M | 18.21%-8.65M | -0.29%-10.75M | 12.74%-9.27M | 26.37%-10.34M | 23.14%-45.96M | 15.06%-10.57M | 28.18%-10.72M | 27.43%-10.62M |
| Net income continuous Operations | -13.46%-11.73M | 15.12%-39.01M | 18.21%-8.65M | -0.29%-10.75M | 12.74%-9.27M | 26.37%-10.34M | 23.14%-45.96M | 15.06%-10.57M | 28.18%-10.72M | 27.43%-10.62M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -13.46%-11.73M | 15.12%-39.01M | 18.21%-8.65M | -0.29%-10.75M | 12.74%-9.27M | 26.37%-10.34M | 23.14%-45.96M | 15.06%-10.57M | 28.18%-10.72M | 27.43%-10.62M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -13.46%-11.73M | 15.12%-39.01M | 18.21%-8.65M | -0.29%-10.75M | 12.74%-9.27M | 26.37%-10.34M | 23.14%-45.96M | 15.06%-10.57M | 28.18%-10.72M | 27.43%-10.62M |
| Basic earnings per share | -10.00%-0.55 | 19.03%-1.83 | 23.08%-0.4 | 5.66%-0.5 | 18.87%-0.43 | 28.57%-0.5 | 27.56%-2.26 | 16.13%-0.52 | 30.26%-0.53 | 29.33%-0.53 |
| Diluted earnings per share | -10.00%-0.55 | 19.03%-1.83 | 23.08%-0.4 | 5.66%-0.5 | 18.87%-0.43 | 28.57%-0.5 | 27.56%-2.26 | 16.13%-0.52 | 30.26%-0.53 | 29.33%-0.53 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025